
Keysight reported fiscal Q3 non-GAAP EPS of $3.07 on $1.85B revenue, beating consensus ($2.48 EPS, $1.75B sales) with revenue up 37% YoY and adjusted EPS up 78.5%. Full-year guidance also topped Street expectations ($1.93B–$1.95B sales vs. $1.83B; $3.34–$3.40 EPS vs. $2.68). However, management warned supply-chain component constraints could pressure next fiscal year sales growth and margins, contributing to the stock’s -11.7% pullback despite the beats.
The market is treating this as a quality-growth de-rating event, not a demand miss. For a test-and-measure name, supply constraints matter first through shipment timing and factory under-absorption: you can have a strong order environment and still get softer EPS if components force partial builds, higher expedite costs, or lower mix efficiency. That makes the next 1-2 quarters the key window, not the reported quarter.
Second-order, this is more idiosyncratic than a broad read-through on AI capex. If KEYS is constrained on components, the spillover is to peers with similar BOM fragility and to customers whose qualification cycles depend on timely instrumentation, which can push out revenue recognition across semis, RF, and industrial end markets. I would not extrapolate this to NVDA-demand weakness; if anything, it says equipment demand remains healthy enough to stress the supply chain.
The contrarian point is that the selloff may be too large if backlog converts normally once parts loosen. But if management cannot show margin protection on the next call, the stock deserves a lower multiple because the market will stop paying a premium for growth that is bottlenecked internally. Falsifier: a clean sequential margin hold and reaffirmed FY guide with commentary that constraints are temporary and already easing.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.05
Ticker Sentiment